why is AstraZeneca withdrawing its vaccine from the market? | EUROtoday
Get real time updates directly on you device, subscribe now.
VS'was one of many first to be put in the marketplace in 2021. The AstraZeneca group's Covid-19 vaccine was withdrawn from the market on Tuesday, May 7, and manufacturing was stopped, as revealed by the newspaper The Telegraph.
The trigger: a drastic drop in gross sales whereas greater than three billion doses have been distributed in three years world wide. In a press launch, the producer reviews a “decline in demand” in addition to a “surplus of updated vaccines” within the face of various variants of the virus.
The pharmaceutical big can also be the goal of a category motion within the United Kingdom, for uncommon instances of thrombosis. This syndrome causes the formation of a blood clot with probably deadly penalties. The phenomenon remained uncommon because it occurred in roughly 2 to three individuals out of 100,000 who have been vaccinated with the AstraZeneca serum. In the United Kingdom, 51 plaintiffs took the laboratory to court docket.
AstraZeneca desires to “close the chapter”
On the French facet, in March 2021, twelve instances of thrombosis together with 4 deaths have been reported, out of two.5 million AstraZeneca injections. Doubt led to the suspension of the vaccine in a number of international locations together with the United Kingdom, Norway and Denmark. Canada and Germany had chosen to solely prescribe it for older individuals.
At the beginning of 2021, AstraZeneca was one of many first to place its vaccine in the marketplace after the Americans Pfizer-BioNTech and Moderna. But it skilled a number of issues together with a hoped-for commercialization within the United States which by no means occurred. In Europe, supply issues have been added to instances of thrombosis.
READ ALSO Covid-19: what we all know, three years after the beginning of the pandemicThe British laboratory now desires to “close the chapter” and says it’s “incredibly proud of the role that Vaxzevria played in ending the pandemic”, indicating that “according to independent estimates, more than 6.5 million lives have been saved during the first year of use alone” of the serum.
https://www.lepoint.fr/sante/covid-19-pourquoi-astrazeneca-retire-son-vaccin-du-marche-08-05-2024-2559766_40.php